PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1235929
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1235929
According to Stratistics MRC, the Global Soft Tissue Repair Market is accounted for $13.6 billion in 2022 and is expected to reach $20.1 billion by 2028 growing at a CAGR of 6.7% during the forecast period. Soft tissues injuries involve harm to the muscles, ligaments and tendons that will result in the inflammation as well as pain. Soft tissue repair is accomplished by replacing injured or damaged tissues with healthy tissues. The current treatment options are heavily reliant on surgical methods with a low success rate. As a result, prevalent, innovatively advanced options such as minimally invasive processes and rapid healing products are critical.
According to estimates, approximately 3.5 million sports injuries occur in children and teenagers in the United States each year which is further anticipated to propel the growth of the soft tissue repair market. According to the American Journal of Sports Medicine, the incidence of ACL injury is 68.6/100,000 individuals per year.
The growing geriatric population indicates that need for orthopaedic procedures would increase. The rising frequency of trauma injuries and injuries from falls and accidents is predicted to increase the number of trauma operations done globally. Hence, growing geriatric population is propelling the market growth.
The cost and time needed for a product to enter the clinical trial stage are very high, with very low prospects of approval. Soft tissue repair products are classified as class 3 products, which necessitate stringent adherence to regulatory guidelines. Therefore, despite significant investments, there is a high risk of failure, which is hindering the market expanding.
There is a growing awareness of the health advantages of sports and physical activity. This has increased the popularity of sports among the youth. With the increasing sports participation, the number of sport related soft tissue injuries is increased, which is propelling the growth of the market.
The products are extremely competitive in terms of pricing. The adoption of many soft tissue repair products is limited due to their high cost. The products currently available on the market are made of complicated reconstitutions with a poor shelf life. Hence, these are the prospects hampering the market growth.
The pandemic of COVID-19 has had a huge impact on the soft tissue repair market. The crisis and the ensuing lockdowns had severe operational and economic consequences across the industrial spectrum. The market also felt the heat of the outbreak as a result of rising disruptions in health care services, particularly the care of patients with wounds, which resulted in significant shifts in the delivery of wound care. However, the concerns over pressure-induced skin as well as soft tissue injuries in the affected patients is expected to rise in the pandemic.
The hernia repair segment is estimated to have a lucrative growth, due to increase in soft tissue repair surgeries. It is expanding as a result of numerous additional factors, including increased need for improved mesh, increased usage of robotic operations, and the desire for improved mesh, which is boosting the segment's growth.
The clinics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the surging number of patient's preference for clinics for quality care. Furthermore, the majority of clinics are emphasising the need of providing cost-effective, high-quality, and individualised services, which is anticipated to increase product adoption.
Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases. Higher penetration of local manufacturers of medical devices is providing significant growth opportunities for the market in the region.
North America is projected to have the highest CAGR over the forecast period, owing to rise in the demand for soft tissue repair products. Rising healthcare expenditure and investments in healthcare infrastructure as an increase in healthcare spending can help make expensive orthopedic soft tissue repair surgeries more affordable which is boosting the growth of the region.
Some of the key players profiled in the Soft Tissue Repair Market include: Allergan Plc., Smith & Nephew PLC, Stryker Corporation, Medtronic Plc., Zimmer Biomet Holdings, Inc., Integra LifeScience Corporation, Isto Biologics, Organogenesis Inc., Depuy Synthes, Wright Medical Group, Inc., Lifenet Health, Inc., American Medical Systems Inc., CryoLife, Inc., Arthrex, Inc., S. Stem Cell, Inc., R. Bard, Inc., LifeCell International Pvt. Ltd., Johnson & Johnson Private Limited, Boston Scientific Corporation and Athersys Inc.
In January 2021, Smith & Nephew acquires the extremely Orthopaedics business of Integra Lifesciences Holdings Corporation.
In December 2019, Medtronic received U.S FDA approval for its Dextile Anatomical Mesh. This hernia repair mesh provides wide coverage of the myopectineal orifice to minimize the risk of recurrence and maintain shape after trocar passage.
All the customers of this report will be entitled to receive one of the following free customization options:
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.